Current Opportunities

Atsena Therapeutics Process Development Opportunity

October 21, 2021
The Chase Group is pleased to announce their continued partnership with Atsena Therapeutics after being retained to execute a search for an Associate Director/Director of… Continue Reading →

Arcturus Retains The Chase Group to Expand Vaccine Development Programs

October 19, 2021
As part of its growth strategy, Arcturus Therapeutics has partnered with The Chase Group to build and expand their vaccines development team. Founded in 2013… Continue Reading →

Alexza Pharmaceuticals Partnership Continues with Quality Assurance Leadership Search

August 4, 2021
Alexza Pharmaceuticals continues to partner with The Chase Group to secure a Senior Director/Head, Quality Assurance. The Chase Group is currently seeking quality assurance professionals… Continue Reading →

Atsena Therapeutics Retains The Chase Group to Identify Head of Regulatory

July 28, 2021
Atsena Therapeutics has retained The Chase Group to identify a Head of Regulatory. Chase is proud to partner with this clinical-stage ocular gene therapy company… Continue Reading →

Ventria Continues Partnership With The Chase Group to Find Agronomy Operations Leader

July 27, 2021
Ventria Bioscience has partnered once again with The Chase Group to continue building their leadership team as they develop and commercialize innovative medicines with an… Continue Reading →

Ferrer Partners With The Chase Group to Identify US Business Development Leader

March 18, 2021
The Chase Group’s successful partnership with Alexza Pharmaceuticals has extended to include their parent company, Ferrer. A privately held company based in Barcelona, Spain, Ferrer… Continue Reading →

Alexza Pharmaceuticals Continues Partnership With The Chase Group to Seek Clinical Operations Leader

January 27, 2021
Alexza Pharmaceuticals, backed by their parent company, Ferrer, is working to develop products for the acute treatment of underserved medical needs in neuroscience. The company… Continue Reading →

Head of Drug Safety Search Expands Partnership of Arcturus Therapeutics and The Chase Group

November 24, 2020
Arcturus Therapeutics is a growing company with a versatile portfolio and cutting-edge mRNA technology that can be adapted to multiple disease areas. New to clinical… Continue Reading →

The Chase Group Retained to Identify Pulmonary and Rare Disease Clinical Development Leader for Arcturus Therapeutics

The combination of expertise and passion to build transformative, life-changing medicines for patients and their families positions Arcturus Therapeutics to catalyze the next generation of… Continue Reading →

Akcea Therapeutics Turns to The Chase Group to Secure Chief Medical Officer

April 29, 2020
Akcea Therapeutics is focused on helping patients living with rare diseases by understanding patient and physician needs by bringing transformative medicines to market. Akcea is… Continue Reading →
Copyright © 1993-2025 The Chase Group. All Rights Reserved.